Cargando…

Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments

There is increasing evidence that neurofilament light chain (NF-L) can be considered as a biomarker for neuro-axonal damage. This polypeptide can be released into the cerebrospinal fluid (CSF) and the blood, where it can be quantified. The concentration of NF-L is elevated in patients with multiple...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tauil, C.B., Rocha-Lima, A.D., Ferrari, B.B., da Silva, F.M., Machado, L.A., Ramari, C., Brandão, C.O., dos Santos, L.M.B., dos Santos-Neto, L.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Associação Brasileira de Divulgação Científica 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812914/ https://www.ncbi.nlm.nih.gov/pubmed/33470393 http://dx.doi.org/10.1590/1414-431X202010428

Ejemplares similares

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines
por: Tauil, Carlos B., et al.
Publicado: (2020)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
por: Lin, Jonathan B, et al.
Publicado: (2023)

Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration
por: Weston, Philip S.J., et al.
Publicado: (2017)

The effect of lumbar puncture on the neurodegeneration biomarker neurofilament light in macaque monkeys
por: Boehnke, Susan E., et al.
Publicado: (2020)

Neurofilament Proteins as Body Fluid Biomarkers of Neurodegeneration in Multiple Sclerosis
por: Gresle, Melissa M., et al.
Publicado: (2011)

Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome
por: Strydom, Andre, et al.
Publicado: (2018)

Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease
por: Mattsson, Niklas, et al.
Publicado: (2017)

Neurofilament Light Chain Is a Biomarker of Neurodegeneration in Ataxia Telangiectasia
por: Donath, H., et al.
Publicado: (2021)

Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma
por: Sveijer, Malin, et al.
Publicado: (2022)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
por: Wang, Hongge, et al.
Publicado: (2022)

Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy
por: Weinhofer, Isabelle, et al.
Publicado: (2021)

Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease
por: Lewczuk, Piotr, et al.
Publicado: (2018)

Plasma Neurofilament Light: A Marker of Neurodegeneration in Mild Behavioral Impairment
por: Naude, James P., et al.
Publicado: (2020)

Uman-type neurofilament light antibodies are effective reagents for the imaging of neurodegeneration
por: Shaw, Gerry, et al.
Publicado: (2023)

Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis
por: Byrne, Lauren M, et al.
Publicado: (2017)

Neurofilaments: The C-Reactive Protein of Neurology
por: Lambertsen, Kate L., et al.
Publicado: (2020)

The role of neurofilament aggregation in neurodegeneration: lessons from rare inherited neurological disorders
por: Didonna, Alessandro, et al.
Publicado: (2019)

Plasma neurofilament light chain as a potential biomarker of neurodegeneration in murine brain
por: Sano, Tomoya, et al.
Publicado: (2023)

Heads Up! Interlinked Amyloidogenic and Axonal Transport Pathways in Concussion-Induced Neurodegeneration
por: Almenar-Queralt, Angels, et al.
Publicado: (2022)

Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes
por: Marks, Jordan D., et al.
Publicado: (2021)

Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer’s disease
por: Sánchez-Valle, Raquel, et al.
Publicado: (2018)

CSF Neurofilament Light Chain Levels in Primary Progressive MS: Signs of Axonal Neurodegeneration
por: Pawlitzki, Marc, et al.
Publicado: (2018)

Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer’s disease
por: Andersson, Emelie, et al.
Publicado: (2020)

Neurofilament light chain and retinal layers' determinants and association: A population‐based study
por: Garzone, Davide, et al.
Publicado: (2022)

QUALITY OF LIFE, PAIN, ANXIETY AND DEPRESSION IN PATIENTS SURGICALLY TREATED WITH CANCER OF RECTUM
por: SANTOS, Letácio José Freire, et al.
Publicado: (2014)

Incorporating the patient perspective in the study of rare bone disease: insights from the osteogenesis imperfecta community
por: Swezey, T., et al.
Publicado: (2018)

Neuroinflammation and Neurodegeneration: Pinpointing Pathological and Pharmacological Targets
por: de Oliveira, Antonio Carlos Pinheiro, et al.
Publicado: (2015)

Phosphorylated neurofilament heavy chain is a marker of neurodegeneration in Leber hereditary optic neuropathy (LHON)
por: Guy, John, et al.
Publicado: (2008)

Neurofilament light chain plasma concentration predicts neurodegeneration and clinical progression in nondemented elderly adults
por: Hu, Hao, et al.
Publicado: (2019)

Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease
por: Moscoso, Alexis, et al.
Publicado: (2021)

Influence of a GSK3β phosphorylation site within the proximal C-terminus of Neurofilament-H on neurofilament dynamics
por: Vohnoutka, Rishel Brenna, et al.
Publicado: (2017)

Decreased Neurofilament L Chain Levels in Cerebrospinal Fluid and Tolerogenic Plasmacytoid Dendritic Cells in Natalizumab-Treated Multiple Sclerosis Patients – Brief Research Report
por: Moraes, Adriel S., et al.
Publicado: (2021)

Absence of the Mid-sized Neurofilament Subunit Decreases Axonal Calibers, Levels of Light Neurofilament (NF-L), and Neurofilament Content
por: Elder, Gregory A., et al.
Publicado: (1998)

Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
por: Delaby, C., et al.
Publicado: (2020)

Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population
por: Gleerup, Helena Sophia, et al.
Publicado: (2021)

A New Mouse Model of Giant Axonal Neuropathy with Overt Phenotypes and Neurodegeneration Driven by Neurofilament Disorganization
por: Nath, Banshi, et al.
Publicado: (2023)

Cerebrospinal Fluid Levels of Phosphorylated Neurofilament Heavy as a Diagnostic Marker of Canine Degenerative Myelopathy
por: Toedebusch, C.M., et al.
Publicado: (2017)

Neurofilament-dependent Radial Growth of Motor Axons and Axonal Organization of Neurofilaments Does Not Require the Neurofilament Heavy Subunit (NF-H) or Its Phosphorylation
por: Rao, Mala V., et al.
Publicado: (1998)

Neurofilament Light Protein as a Potential Blood Biomarker for Huntington's Disease in Children
por: Byrne, Lauren M., et al.
Publicado: (2022)

Mechanisms and Consequences of Dopamine Depletion-Induced Attenuation of the Spinophilin/Neurofilament Medium Interaction
por: Hiday, Andrew C., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_mt207o2qfoj9cq3bvcq4mjf8mb